The Centers for Disease Control and Prevention (CDC) recently introduced new guidelines for the use of doxycycline, an antibiotic, as a post-exposure preventive treatment for bacterial sexually transmitted infections (STIs) such as chlamydia, syphilis, and gonorrhea. These guidelines aim to address the rising rates of STIs in the United States, which the CDC has referred to as an "epidemic." The recommendations are open for a 45-day public comment period involving physicians and public health officials before finalization.

The proposal acknowledges the importance of discussing risk reduction strategies, particularly for gay and bisexual men and transgender women who face an increased risk of STIs. However, the article questions the cultural messaging around sexuality and promiscuity, highlighting that all sexual activity carries some level of health risk. It underscores the importance of considering factors like skin-to-skin contact and the potential transmission of STIs through various sexual behaviors, including oral sex. Additionally, it raises concerns about the implications of antibiotic use in STI prevention, including the risk of antibiotic resistance, especially if these preventive measures become widespread and readily available. Overall, the article encourages a more comprehensive and nuanced approach to addressing the growing STI problem in the United States.

Read the full article here: https://www.washingtonexaminer.com/restoring-america/community-family/safer-sex-means-less-promiscuity-not-more